Evidence map›Paper›PMID 37109674›Full record

ArticleMedicina (Kaunas, Lithuania)2023

Bioinformatics Prediction and Experimental Verification Identify CAB39L as a Diagnostic and Prognostic Biomarker of Kidney Renal Clear Cell Carcinoma.

Yunfei Wu, Zhijie Xu, Xiaoyi Chen, Guanghou Fu, Junjie Tian, Yue Shi, Junjie Sun, Baiye Jin

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Medicina (Kaunas, Lithuania), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.8field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 7 citations in OpenAlex.

  1. Association ofTranslational cancer research · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Yunfei WuDepartment of Urology, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou 310009, China.
Zhijie XuDepartment of Urology, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou 310009, China.
Xiaoyi ChenDepartment of Urology, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou 310009, China.
Guanghou FuDepartment of Urology, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou 310009, China.ORCID 0000-0003-4243-3894
Junjie TianDepartment of Urology, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou 310009, China.
Yue ShiDepartment of Urology, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou 310009, China.
Junjie SunDepartment of Urology, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou 310009, China.
Baiye JinDepartment of Urology, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou 310009, China.ORCID 0000-0002-6667-0424
Zhejiang University · CN

Funding

Key Project of Science and Technology Program of Zhejiang Province grant no. 2020C03026
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Carcinoma, Renal CellKidney NeoplasmsBiomarkersComputational BiologyHumansKidneyPrognosisBiomarkersdiagnosiskidney renal clear cell carcinomaprognosis

Identifiers

PMID37109674
PMCPMC10145756
OpenAlexW4362667328

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.